Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06139757 · ClinicalTrials.gov registry record
Sleep Length and Euploid Embryo Transfer Prospective Study
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 150
- Enrollment target
NCT06139757: Completed study, sponsored by Northwestern University.
NCT06139757 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06139757 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Sleep is a critical component of daily life that significantly influences health and well-being. Despite the integral role sleep plays in life, its effect on women's reproductive health, and its subsequent impact on fertility, is largely understudied. The purpose of the SLEEP Study is to investigate the link between sleep and fertility. Participants will use a wireless wearable device mounted on the finger to measure sleep in the weeks preceding and following an embryo transfer during treatment with in vitro fertilization. The investigators hope that these findings will inform future therapies that improve sleep and fertility outcomes.
Primary Outcome
To elucidate a potential correlation between average total sleep time and other sleep parameters (sleep efficiency, wake after sleep onset, and sleep stages) during the pre- and post-embryo transfer windows on rates of implantation, clinical pregnancy, ongoing pregnancy, and miscarriage.
Interventions
- DEVICE Oura ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-01-17 |
| Est. Completion | 2025-07-31 |
What the finished NCT06139757 record still lists
NCT06139757 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Oura ring is the first listed.
NCT06139757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06139757 about?
NCT06139757 is a clinical study titled "Sleep Length and Euploid Embryo Transfer Prospective Study". Sleep is a critical component of daily life that significantly influences health and well-being. Despite the integral role sleep plays in life, its effect on women's reproductive health, and its subsequent impact on fertility, is largely understudied. The purpose of the SLEEP Study is to investigate...
What is the current status of trial NCT06139757?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2024-01-17. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT06139757?
The interventions under investigation include: Oura ring (DEVICE).
Who is sponsoring clinical trial NCT06139757?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI